Draft:Alison Chiu

Alison Chiu
File:Alison Chiu portrait.jpg
Dr. Alison Chiu, ophthalmologist
EducationUniversity of Sydney
OccupationOphthalmologist
Known forRefractive surgery, cataract surgery

Alison Chiu is an Australian ophthalmologist and eye surgeon based in Sydney. She is a Clinical Senior Lecturer at the University of Sydney and specialises in cataract surgery, refractive surgery, and the treatment of presbyopia. She is a Federal Councillor of the Royal Australian and New Zealand College of Ophthalmologists (RANZCO).[1] Her work includes refractive cataract surgery and she has been profiled in national and international media, including the Australian Financial Review and Master Insight.[2][3]

Early life and education

Chiu pursued her medical education in Australia. In 1996, during her student years, her work was mentioned in The Australian in an article on forensic dentistry titled "Forensic bytes from students' jaws".[4]

She holds an academic appointment at the University of Sydney Medical School.[5]

Career

Chiu is a consultant ophthalmologist specialising in vision correction surgery. Her clinical work includes advanced intraocular lenses (IOLs) and laser vision correction. She has been featured in the Australian Financial Review, where she discussed the demands of ophthalmic surgery and patient care.[2]

She has been involved in the adoption and evaluation of new surgical technologies. She was the first surgeon in Australia and New Zealand to implant the EVO Viva presbyopia-correcting Implantable Collamer Lens (ICL), as noted in her interview with Master Insight.[3] She has contributed to professional discussions on Extended Depth of Focus (EDOF) intraocular lenses and shared-care models for ICL procedures.[6][7]

Chiu regularly presents at professional conferences including events hosted by the Australian Society of Cataract and Refractive Surgeons (AUSCRS) and GenEye.[8][9]

Research and publications

Chiu contributes to clinical research in ophthalmology and has served as a principal investigator for clinical trials.

  • Clinical trials: Registered investigator for ophthalmic clinical studies approved by the Bellberry Human Research Ethics Committee (HREC 2024-05-669).
  • Publications: Author of peer-reviewed research published in the Asia-Pacific Journal of Ophthalmology.[10]

Professional roles

Chiu is involved in governance and education through the Royal Australian and New Zealand College of Ophthalmologists (RANZCO). Her roles have included serving as an examiner, membership of the NSW Branch Executive Committee, and participation in college committees.[11][12][1]

She is also a Clinical Senior Lecturer at the University of Sydney.[5]

Media coverage

Chiu has been featured in Australian and international media, including the Australian Financial Review and Master Insight. She is frequently interviewed by industry publications such as MiVision regarding clinical outcomes and emerging optical technologies.[13]

Awards and recognition

  • 2025: Named "Best Cataract Surgeon in Australia" by Best of Best Review.[14]

References

  1. ^ a b RANZCO Annual Report 2024 (Report). Royal Australian and New Zealand College of Ophthalmologists. Retrieved 2025-11-30.
  2. ^ a b Needham, Kirsty (2023-03-07). "The one thing this top surgeon is rubbish at". Australian Financial Review.
  3. ^ a b "Dr. Alison Chiu Interview" (in English and Chinese). Master Insight. Retrieved 2025-11-30.
  4. ^ "Forensic bytes from students' jaws". Higher Education. The Australian. 1996-10-02. p. 39.
  5. ^ a b "Academic Staff: Dr Alison (Lan See) Chiu". University of Sydney. Retrieved 2025-11-30.
  6. ^ "Right on Target: ELON Extended Depth of Focus IOL". MiVision. November 2024.
  7. ^ "All You Need to Know for STAAR ICL Shared Care". MiVision. February 2024.
  8. ^ "GenEye 2024: Innovate and Explore". MiVision. September 2024.
  9. ^ "AUSCRS 2024: The I-Land Creating Connections". MiVision. August 2024.
  10. ^ Lai KHW; Wang, X. Y.; Wan, K. H.; Barsam, A.; Barnes, S. D.; Chiu ALS; Cummings, A. B.; Eldanasoury, A. M.; Huang, G.; Kamiya, K.; Leyssens, B.; Li, S. M.; Packer, M.; Stevens, J.; Yoo, T. K.; Yeo, L.; Zhan, X.; Lam DSC; Zhou, X. (2025). "Publication". Asia-Pacific Journal of Ophthalmology. 14 (4). doi:10.1016/j.apjo.2025.100222. PMID 40588076.
  11. ^ RANZCO Annual Report 2020 (Report). Royal Australian and New Zealand College of Ophthalmologists. Retrieved 2025-11-30.
  12. ^ RANZCO Annual Report 2018–2019 (PDF) (Report). Royal Australian and New Zealand College of Ophthalmologists. Retrieved 2025-11-30.
  13. ^ "Real World Results with ELON EDOF IOLs". MiVision. November 2024.
  14. ^ "Pure Sight Eye Surgeons: Best Cataract Surgeon in Australia of 2025". Best of Best Review. Retrieved 2025-11-30.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.